Recently Approved and Under Investigation Drugs for Treating Patients with Heart Failure

Heart Failure (HF) represents a leading cause of morbidity and mortality worldwide. Despite the recent advances in the treatment of this condition, patients´ prognosis remains unfavorable in most cases. Sacubitril/valsartan and ivabradine have been recently approved to improve clinical outcomes in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro-Torres, Yaniel, Katholi, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536816/
https://www.ncbi.nlm.nih.gov/pubmed/32351188
http://dx.doi.org/10.2174/1573403X14666180702151626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536816/
https://www.ncbi.nlm.nih.gov/pubmed/32351188
http://dx.doi.org/10.2174/1573403X14666180702151626

Ejemplares similares